Actively Recruiting

Age: 18Years +
All Genders
NCT05817591

Response Profiles to High-concentration Capsaicin Desensitization in Patients with Peripheral Neuropathic Pain with or Without Allodynia: a Regional Multicenter Prospective Cohort

Led by Centre Hospitalier Annecy Genevois · Updated on 2025-02-13

400

Participants Needed

10

Research Sites

130 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Prospective multicenter cohort to determine patient profiles (associated factors, including allodynia) with a better response to pain desensitization by capsaicin delivered in the form of a high concentration patch (8%), in a population of patients with peripheral neuropathic pain and followed up in a pain consultation in the Auvergne Rhône Alpes region.

CONDITIONS

Official Title

Response Profiles to High-concentration Capsaicin Desensitization in Patients with Peripheral Neuropathic Pain with or Without Allodynia: a Regional Multicenter Prospective Cohort

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient over 18 years of age on the day of inclusion
  • Patient who has been informed and has not expressed opposition to participating in the study
  • Patient with peripheral neuropathic pain defined by a Neuropathic Pain 4 (DN4) score of 4 or higher
  • Patient with pain greater than 4 on the numerical pain scale
  • Patient on stable pain treatment for at least 1 month
  • Patient with or without mechanical allodynia as determined by Brush and Von Frey tests
  • Patient with or without thermal allodynia to hot or cold as determined by ROLLTEMP-II® device
  • Patient suitable for desensitization by high concentration capsaicin patch without contraindications
  • Patient who has not previously used high concentration capsaicin on the affected area
  • Patient who understands French
Not Eligible

You will not qualify if you...

  • Patient with pain related to complex regional pain syndrome
  • Patient with active cancer
  • Patient who has received Botulinum toxin A in the affected area within the last 3 months
  • Patient with planned surgery on the painful site within the next 12 months
  • Patient currently enrolled in an interventional research protocol
  • Patient under guardianship, curatorship, or legal protection

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 10 locations

1

Centre Hospitalier Annecy Genevois

Annecy, France, 74370

Actively Recruiting

2

Hospices Civils de Lyon, Hôpital Pierre Wertheimer

Bron, France, 69500

Not Yet Recruiting

3

Centre Hospitalier Métropole Savoie

Chambéry, France, 73000

Actively Recruiting

4

Centre Hospitalier Universitaire de Clermont-Ferrand

Clermont-Ferrand, France, 63000

Not Yet Recruiting

5

Centre Hospitalier Universitaire Grenoble-Alpes

Grenoble, France, 38043

Actively Recruiting

6

Hospices Civils de Lyon, Hôpital de la Croix Rousse

Lyon, France, 69317

Not Yet Recruiting

7

Centre Léon Bérard

Lyon, France, 69373

Actively Recruiting

8

Centre Hospitalier Universitaire de Saint-Etienne

Saint-Etienne, France, 42055

Not Yet Recruiting

9

Clinique Mutualiste Chirurgicale de Saint Etienne

Saint-Etienne, France, 42100

Actively Recruiting

10

Médipôle Lyon Villeurbanne

Villeurbanne, France, 69100

Not Yet Recruiting

Loading map...

Research Team

M

Marion GHIDI

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here